Cargando…
Visuomotor performance at high altitude in COPD patients. Randomized placebo-controlled trial of acetazolamide
Introduction: We evaluated whether exposure to high altitude impairs visuomotor learning in lowlanders with chronic obstructive pulmonary disease (COPD) and whether this can be prevented by acetazolamide treatment. Methods: 45 patients with COPD, living <800 m, FEV1 ≥40 to <80%predicted, were...
Autores principales: | Scheiwiller, P. M., Furian, M., Buergin, A., Mayer, L. C., Schneider, S. R., Mademilov, M., Lichtblau, M., Muralt, L., Sheraliev, U., Sooronbaev, T. M., Ulrich, S., Bloch, K. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493049/ https://www.ncbi.nlm.nih.gov/pubmed/36160864 http://dx.doi.org/10.3389/fphys.2022.980755 |
Ejemplares similares
-
Effect of acetazolamide on visuomotor performance at high altitude in healthy people 40 years of age or older—RCT
por: Reiser, Aurelia E., et al.
Publicado: (2023) -
Effect of acetazolamide on pulmonary vascular haemodynamics in patients with COPD going to altitude: a randomised, placebo-controlled, double-blind trial
por: Lichtblau, Mona, et al.
Publicado: (2023) -
Effect of Acetazolamide on Postural Control in Patients with COPD Travelling to 3100 m Randomized Trial
por: Buergin, Aline, et al.
Publicado: (2023) -
Validation of a Portable Blood Gas Analyzer for Use in Challenging Field Conditions at High Altitude
por: Nawrocki, Janek, et al.
Publicado: (2021) -
Echocardiography and extravascular lung water during 3 weeks of exposure to high altitude in otherwise healthy asthmatics
por: Saxer, S., et al.
Publicado: (2023)